Click here for the article posted by Lisa Nainggolan on Medscape.
FDA OKs Dapagliflozin to Reduce HF Hospitalization in Diabetes
Grunberger Diabetes Institute Diabetes, Diabetes Medications FDA OKs Dapagliflozin to Reduce HF Hospitalization in Diabetes
Categories:
1 thought on “FDA OKs Dapagliflozin to Reduce HF Hospitalization in Diabetes”
Comments are closed.
Related Posts
What to Know About Zegalogue: A new glucagon rescue
Patients whose diabetes treatment includes insulin will experience hypoglycemic episodes, which occur when most people’s
How to Diagnose a Thyroid Condition
January is Thyroid Awareness Month, so it is only fitting we release an article with
Gvoke: Ready-to-Use Glucagon Pen
Low blood sugar, referred to as hypoglycemia, can be a concerning thought for individuals with
Wonderful post! We are linking to this great post on our site. Leanna Martie Ulrika